Canadian Lung Association honours outstanding contributions to lung health in Canada with King Charles III Coronation Medals
, March 3, 2025 /CNW/ - The Canadian Lung Association is one of a select handful of national organizations that was chosen by the Government of Canada to nominate deserving recipients to receive the King Charles III Coronation Medal.
With input from our partners across the country and the public, we compiled a list of individuals who have made outstanding contributions to lung health in Canada.
From this list, a selection committee identified 39 trailblazers of respiratory research, compassionate and committed clinicians, tireless and determined advocates and inspiring and supportive educators who made the most distinguished and sustained contributions to the field.
The Canadian Lung Association is pleased to present the King Charles III Coronation Medal to the following outstanding individuals:
Dr. Shawn Aaron (ON)
Dr. Anju Anand (ON)
Vibhas Bapat (ON)
Dr. Allan Becker (MB)
Dr. Jean Bourbeau (QC)
MaryAnn Bradley (ON)
Dr. Dina Brooks (ON)
Dr. Pat Camp (BC)
Tina Campbell (SK)
Dr. Christopher Carlsten (BC)
Neil Collishaw (ON)*
Diane Colton (AB)
Dr. Francine Ducharme (QC)
Dr. Andrea Gershon (ON)
Ralph Gouda (ON)
Dr. Brian Graham (SK)
Dr. Samir Gupta (ON)
Dr. Andrew Halayko (MB)
Debbie Homik (MB)
Neil Johnston (MB)
Dr. Alan Kaplan (ON)
Dr. Stephen Lam (BC)
Dr. Larry Lands (QC)
Dr. Richard Leigh (AB)
Trent Litzenberger (SK)
Dr. Diane Lougheed (ON)
David Osborne McDonald (AB)
Lynn McDonald (ON)
Dr. Neeloffer Mookherjee (MB)
Dr. Grace Parraga (ON)
Dr. Christopher Pascoe (MB)
Dr. Graeme Rocker (NS)
Dr. Georg Schmölzer (AB)
Dr. Sanja Stanojevic (NS)
Dr. Elizabeth Tullis (ON)
Barbara Walls (NB)
Dr. Susan Waserman (ON)
Angeline Webb (AB)
Dr. Amy Wong (ON)
* awarded posthumously
Visit lung.ca for a short description of each recipient's contribution to lung health in Canada.
A virtual ceremony will be held in March 2025 to celebrate the remarkable achievements of our recipients and provide a moment of shared recognition.
SOURCE Canadian Lung Association
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2025/03/c6717.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
10 hours ago
- Hamilton Spectator
Premature baby dies with measles
As measles cases across Elgin County and North America continue to rise, a southwestern Ontario infant infected by its unimmunized mother was identified June 5 as Canada's first death related to a measles outbreak that took hold of the nation on Oct. 30, 2024. 'It is with deep sadness that I confirm that an infant, born prematurely and infected with measles, has tragically passed away in southwestern Ontario,' Dr. Kieran Moore, Ontario's Chief Medical Officer of Health said in a statement. Dr. Moore said the infant contracted the virus before birth from the unimmunized mother. While measles may have been a contributing factor in both the premature birth and death, Dr. Moore said that the infant also faced other serious medical complications unrelated to the virus. 'Anyone who is unvaccinated is at risk and I urge everyone, but especially those who may become pregnant, to ensure they have received two doses of the MMR (measles, mumps, and rubella) vaccine, which will protect both a parent and baby,' added Dr. Moore. 'This vaccine has been safely used for over 50 years and is highly effective.' Dr. Ninh Tran, Southwestern Public Health's Medical Officer of Health added: 'This event underscores the seriousness of measles in pregnant individuals, as it can cause low birth weight for the baby, preterm birth, and miscarriage. 'Measles can also cause pneumonia, brain swelling, and death, with infants and immunocompromised individuals especially vulnerable to these risks,' Dr. Tran said in a separate statement. 'The safest and most effective way to protect yourself from measles is through immunization.' The United States has reported 1,088 cases this year, as of June 1, according to a Reuters report. Two children have died in the Texas outbreak. The Government of Canada's latest report shows there are 2,755 measles cases in nine jurisdictions, as of May 24, 2025. That's an increase of 244 measles cases since the previous report. As of June 3, 2025, Ontario has reported a total of 2,009 measles cases in 19 public health units, an increase of 121 cases since the previous week. The weekly provincial report indicates 74.9 percent of measles case in Ontario were infants, children and adolescents, while 24.5 percent were adults. More than 96 percent of all infant, child and adolescent outbreak cases were unimmunized, while 67.3 of adults were unimmunized. A total of 1.9 percent of all cases were pregnant women, with 74.4 percent unimmunized. Six cases of congenital measles, infants diagnosed in the first 10 days of life, have been identified since the Ontario outbreak began on October 30, 2024. SWPH reported 727 cases in the region from Oct 30, 2024 to June 5, 2025, 10 more measles cases since May 29, 2025. More than 74 percent of cases are 18 years old or younger. Nearly 89 percent of cases were unimmunized people. According to the World Health Organization (WHO), before widespread measles vaccinations were available in 1963, major epidemics occurred about every two-to-three years, causing an estimated 2.6 million deaths each year. An estimated 107,500 people died from measles in 2023. Accelerated immunization activities prevented an estimated 60 million deaths from 2000 to 2023, according to WHO. Vaccinations decreased estimated measles deaths from 800,062 in 2000 to 107,500 in 2022. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Yahoo
17 hours ago
- Yahoo
Information and Privacy Commissioner urges government to close regulatory gaps and secure public trust
TORONTO, June 12, 2025 /CNW/ - Ontario's Information and Privacy Commissioner, Patricia Kosseim, is urging the provincial government to address regulatory gaps to better protect Ontarians' personal information from cybersecurity attacks, commercialization of children's data, and the use of AI technologies without clear rules or oversight. The call to action is outlined in the 2024 annual report of the Office of the Information and Privacy Commissioner of Ontario (IPC), From Vision to Impact: Five Years of Privacy and Transparency in a Digital Ontario, released today. The report also includes an appendix containing the IPC's findings and recommendations emerging from a series of access-to-information appeals involving the Greenbelt land removals. "In a world where trust is increasingly hard to come by, Ontarians deserve clear rules, strong safeguards, and full transparency from their institutions," said Commissioner Kosseim. "Whether it's how decisions are made, how personal data is used, or how emerging technologies are governed, our office will continue pushing for real accountability, because public trust is the foundation of a healthy democracy." Make AI and privacy laws work for OntariansThe IPC is urging the government to develop meaningful, enforceable regulations to address key legislative gaps left behind by Bill 194 that enacted the Enhancing Digital Security and Trust Act (EDSTA) and amended the Freedom of Information and Protection of Privacy Act (FIPPA). Specifically, the IPC is calling for: binding guardrails and independent oversight for public sector use of AI robust cybersecurity measures that protect Ontarians' sensitive information stronger and clearer protections for children's digital information amendments to the Municipal Freedom of Information and Protection of Privacy Act to match FIPPA changes. Failing to align the two laws risks creating confusion for institutions and frustration for Ontarians, who expect consistent privacy rights across all of Ontario's public sector Protect patient rights in a digital health systemEnsure that stronger accountability measures are embedded in the Personal Health Information Protection Act and that any future accompanying regulations strengthen meaningful access and protections for individuals' health information, rather than undermine them. Enabling greater access to the electronic health record system through digital health IDs may be a good thing, but not if the system lacks the necessary safeguards, clarity, and transparency. The IPC is calling on the government to retain individuals' full access rights to their health records, embed privacy-enhancing principles into the design of digital health IDs, and ensure strong governance and oversight, particularly when the provision of digital health services involves third-party vendors. Restore transparency and accountability in government decision-makingIn an appendix to its annual report, the IPC examines how the government handled a series of access to information requests related to the Greenbelt land removal decisions. The IPC identified several systemic issues, including: the use of personal devices and email accounts for government-related business, the use of code words that had the effect of frustrating FOI searches, the lack of proper documentation of key government decisions and poor information retention practices. These practices, if left unaddressed, risk undermining transparency and eroding public trust in government institutions. The IPC calls on the government to strengthen its record-keeping policies and practices, prohibit the use of personal accounts and devices for government-related business, regularly monitor for compliance, and codify a legal duty to document communications, decisions, and actions, as well as an explicit requirement for institutions to define and implement appropriate retention measures. The full 2024 annual report, including the Greenbelt appendix and key recommendations, is available on the IPC website. Additional resources: From Vision to Impact: Five Years of Privacy and Transparency in a Digital Ontario, 2024 Annual Report Statistical Report SOURCE Office of the Information and Privacy Commissioner/Ontario View original content to download multimedia: Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
18 hours ago
- Yahoo
CCRAN Announces Its Third Annual Pan-Tumour Biomarkers Conference: Transforming Cancer Care for Patients Through Precision Medicine, Policy, and Partnerships
TORONTO, June 12, 2025 /CNW/ - The Colorectal Cancer Resource & Action Network (CCRAN) proudly announces its third annual Pan-Tumour Biomarkers Conference, taking place virtually June 19 - 20, 2025. As the role of comprehensive genomic profiling (CGP) and biomarker-driven treatments become increasingly vital in cancer care, this event reaffirms CCRAN's position at the forefront of Canada's precision medicine movement. The 2025 Conference arrives at a critical time. With provinces and territories working to align clinical innovation with system delivery, this year's event brings together leaders across healthcare, policy, research, industry, and patient communities to explore what it will take to embed comprehensive genomic profiling (CGP) into the fabric of cancer care - consistently, efficiently, and with long-term sustainability in mind. With a curated agenda centered on health system readiness, policy development and advocacy strategies, the Conference will drive widespread integration of genomic testing, specifically CGP, across cancer care in Canada. From laboratory infrastructure to funding models and clinical adoption, speakers will explore both the science and systems behind matching patients with the most effective treatments for their unique cancer profile. A key highlight of the 2025 Conference is the keynote presentation by the Conference Board of Canada, wherein a groundbreaking cost-benefit analysis will be unveiled to showcase the transformative value of CGP across five tumour types – lung, colorectal, breast, pancreatic and prostate. This study will demonstrate not only the substantial return on investment in modernizing Canada's testing landscape, but more importantly, quantify the profound benefits to patients, including improved survival outcomes, enhanced quality of life, reduced treatment toxicity, and faster access to targeted therapies. This critical data will inform policy decisions and provide compelling evidence for healthcare leaders to accelerate the adoption of precision medicine, ultimately ensuring Canadian cancer patients receive the most effective, personalized care possible. The event also builds on CCRAN's continued efforts to mobilize support for biomarker-driven cancer care through education, policy dialogue, and cross-sector partnerships. CCRAN has played a vital role in amplifying the urgency of public access to biomarker testing and is also helping to align national conversations around the need for timely, standardized, and publicly funded diagnostics. "Precision oncology must be accessible to every Canadian metastatic cancer patient, regardless of geography or circumstance," said Filomena Servidio-Italiano, President & CEO, CCRAN. "This Conference brings together the expertise and momentum required to overcome barriers and chart a clear path forward for advancing genomic testing in Canada's cancer care system." The Conference is designed for healthcare professionals, health system administrators, researchers, policy leaders, patients, caregivers, and all those invested in building a more personalized and equitable future for cancer care in Canada. CCRAN extends its heartfelt gratitude to our premier partners - Merck, AstraZeneca, Roche, Johnson & Johnson - for their unwavering commitment to advancing equitable access to precision medicine in Canada. The organization also expresses its sincere appreciation to the balance of the Conference sponsors as well as the dedicated patient advocacy group partners whose collaboration ensures that the patient voice remains at the heart of every initiative. Registration is free. All sessions will be hosted virtually and made available for post-event register and view the full agenda, visit: CCRAN: The Colorectal Cancer Resource & Action Network (CCRAN) is a national, patient-focused advocacy group that champions the health and well-being of Canadians touched by colorectal cancer, and others at risk of developing the disease. They provide support, education, and advocacy to patients (and their caregivers) to help improve patients' quality of life, as well as their longevity. SOURCE Colorectal Cancer Resource & Action Network (CCRAN) View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
